cAMP-dependent protein kinase inhibitor beta (PKIβ)

cAMP-dependent protein kinase inhibitor beta (PKIβ) is a member of the heat-stable protein kinase inhibitor (PKI) family that acts as a potent negative regulator of PKA by binding to its catalytic subunit and blocking substrate phosphorylation in a pseudosubstrate-like manner. The PKI family includes α, β, and γ isoforms, each of which plays a role in shaping cAMP/PKA-dependent signaling dynamics in various tissues. PKIβ modulates cell signaling by governing PKA activity, thus influencing processes such as cell cycle, apoptosis, gene transcription (via CREB), and metabolic regulation. This protein does not act as a classic therapeutic receptor or enzyme, but is a critical part of kinase-based regulatory networks. Its main therapeutic relevance is as a modulator within the cAMP/PKA pathway, making the pathway itself a major target for small molecule kinase inhibitors (not directly aimed at PKIβ, but at the broader complex). Therapeutic agents modulating PKA/PKI dynamics are under active investigation in cancer, inflammation, cardiovascular, and neurological diseases.

Other names

PKIβcAMP-dependent protein kinase inhibitor betaProtein kinase inhibitor betaHeat-stable protein kinase inhibitor beta

Inhibition of PKA catalytic subunits by competitive binding (pseudosubstrate inhibition); Drugs acting upstream/downstream of PKA modulate PKI/PKA interaction